Immune System News and Research

RSS

New compound blocks action of key 'gatekeeper' enzyme for malaria parasite survival

Melbourne researchers are homing in on a new target for malaria treatment, after developing a compound that blocks the action of a key 'gatekeeper' enzyme essential for malaria parasite survival.

2 Jul 2014

Children who undergo simple emergency surgeries on weekends are more likely to die

Children who undergo simple emergency surgeries, such as hernia repairs or appendix removals, on weekends are more likely to suffer complications and even die than children getting the same kind of treatment during the week, according to results of a Johns Hopkins Children's Center study.

1 Jul 2014

Prophage autologous cancer vaccine extends survival in patients with newly diagnosed GBM

Agenus Inc., announced final results from a single-arm, multi-institutional, open-label, Phase 2 study showing that patients with newly diagnosed glioblastoma multiforme (GBM) who received Agenus' Prophage autologous cancer vaccine added to the standard of care treatment, lived nearly twice as long as expected.

1 Jul 2014

Gateway Apothecary wins Peter M. Fox Excellence in HIV Credentialing Award for 2014

Gateway Apothecary in St. Louis, Mo., has received a Peter M. Fox Excellence in HIV Credentialing Award for 2014. Gateway was the only pharmacy to be recognized among the 17 nationwide award recipients, which consist primarily of physicians and/or medical practices.

1 Jul 2014

Research shows foodborne pathogen can cause disease in some breeds of poultry

Contrary to popular belief, the foodborne pathogen Campylobacter jejuni is not a harmless commensal in chickens but can cause disease in some breeds of poultry according to research published in mBio-, the online open-access journal of the American Society for Microbiology.

1 Jul 2014

Heavy drinkers at greater risk of developing pneumonia and ARDS

Heavy drinking damages the body in many ways. In addition to liver failure, alcoholics are at a much greater risk of developing pneumonia and life threatening acute respiratory distress syndrome (ARDS), for which there is no treatment.

1 Jul 2014

Researchers identify new protein as possible therapeutic target for pancreatic cancer

Researchers from IMIM (Hospital del Mar Medical Research Institute) have identified a new protein, galectin-1, as a possible therapeutic target for pancreatic cancer.

1 Jul 2014

HIV-positive people with early-stage cancer less likely to get cancer treatment

HIV-infected people diagnosed with cancer are two to four times more likely to go untreated for their cancer compared to uninfected cancer patients, according to a new, large retrospective study from researchers in Penn Medicine's Abramson Cancer Center and the National Cancer Institute (NCI) published online ahead of print in the Journal of Clinical Oncology.

1 Jul 2014

New approach may help develop more effective immunotherapy for metastatic melanoma

A new approach demonstrated that the recognition of unique cancer mutations appeared to be responsible for complete cancer regressions in two metastatic melanoma patients treated with a type of immunotherapy called adoptive T-cell therapy.

1 Jul 2014

Researchers find unique cell type that can protect against uveitis

Researchers at the National Eye Institute (NEI) have found a unique cell type that, in tests on mice, can protect against uveitis—a group of inflammatory diseases that affect the eye and can cause vision loss.

1 Jul 2014

ANMAT approves Genzyme’s Lemtrada for treatment of relapsing remitting multiple sclerosis

Genzyme, a Sanofi company (EURONEXT:SAN and NYSE:SNY), announced today that Argentina's National Administration of Drugs, Food and Medical Technology (ANMAT) has approved LemtradaTM (alemtuzumab) for adult patients with relapsing remitting multiple sclerosis (RRMS) with active disease defined by clinical or imaging features.

30 Jun 2014

Cidara Therapeutics closes $32M Series A financing to advance novel echinocandin antifungal drug

Cidara Therapeutics, Inc., a privately held biopharmaceutical company, announced today that it has completed a $32 million Series A financing that will enable it to advance candidates from the company's Cloudbreak™ targeted immunotherapy platform and biafungin™, a novel long acting echinocandin antifungal drug, into human clinical studies.

30 Jun 2014

Complete analysis of regenerative medicine market

According to a new market research report by Allied Market Research titled, "GlobalRegenerative MedicineMarket (Technology, Applications, Geography) - Industry Analysis, Trends, Opportunities and Forecast, 2013-2020", the global regenerative medicine market will reach $ 67.6 billion by 2020 from $16.4 billion in 2013, registering a CAGR of 23.2% during forecast period (2014 - 2020).

30 Jun 2014

Switching off a single gene converts human gastrointestinal cells into insulin-producing cells

By switching off a single gene, scientists at Columbia University's Naomi Berrie Diabetes Center have converted human gastrointestinal cells into insulin-producing cells, demonstrating in principle that a drug could retrain cells inside a person's GI tract to produce insulin.

30 Jun 2014

Immune System News and Research

New compound blocks action of key 'gatekeeper' enzyme for malaria parasite survival

Children who undergo simple emergency surgeries on weekends are more likely to die

Prophage autologous cancer vaccine extends survival in patients with newly diagnosed GBM

Gateway Apothecary wins Peter M. Fox Excellence in HIV Credentialing Award for 2014

Research shows foodborne pathogen can cause disease in some breeds of poultry

Heavy drinkers at greater risk of developing pneumonia and ARDS

Researchers identify new protein as possible therapeutic target for pancreatic cancer

HIV-positive people with early-stage cancer less likely to get cancer treatment

New approach may help develop more effective immunotherapy for metastatic melanoma

Researchers find unique cell type that can protect against uveitis

ANMAT approves Genzyme’s Lemtrada for treatment of relapsing remitting multiple sclerosis

Cidara Therapeutics closes $32M Series A financing to advance novel echinocandin antifungal drug

Complete analysis of regenerative medicine market

Switching off a single gene converts human gastrointestinal cells into insulin-producing cells

Karolinska Institute Professor calls for innovative solutions for global healthcare

Host-directed therapy: A new type of TB treatment

Some cancer patients with aggressive tumors may benefit from anti-inflammatory drugs

Interactions with other infections can trigger herpes virus to reactivate, shows research

New technology could revolutionize treatment and prevention of sepsis

Scientists report first successful step toward vaccine that targets mutation in brain cancer

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News